title: A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism.
abstract: 5, 10-Methylenetetrahydrofolate reductase (MTHFR) is a crucial enzyme in homocysteine/methionine metabolism. The most-studied C677T polymorphism in the MTHFR gene results in a thermolabile variant with reduced activity, and is associated with increased levels of total plasma homocysteine, a risk factor for coronary artery disease. A new mutation in the MTHFR gene (A1298C) has also been reported to lower enzyme activity. Whether A1298C is a risk factor for coronary artery disease, separately or in combination with C677T, and/or relative to total plasma homocysteine and folate status, is unclear to date. We evaluated this hypothesis in 470 angiographically characterized subjects, 302 with coronary artery disease, and 168 with normal coronary arteries. The frequency of the 1298C allele was 0.33 and that of combined heterozygosity 0.315. No difference was found in the frequency of the genotypes or when analyzed for combined heterozygosity between patients with coronary artery disease and normals. Independent of folate status, the 1298C allele was not associated with increased total plasma homocysteine. No additional effect of A1298C on total plasma homocysteine was observed in 148 combined heterozygotes compared with 98 heterozygotes for the C677T alone. These findings do not support a major role for the A1298C mutation in homocysteine metabolism and emphasize the hypothesis that MTHFR genotypes may interfere with coronary artery disease risk only when an unbalanced nutritional status leads to raised total plasma homocysteine levels.
authors.affiliation: Department of Clinical and Experimental Medicine, University of Verona, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Friso
authors.forename: D
authors.initials: D
authors.lastname: Girelli
authors.forename: E
authors.initials: E
authors.lastname: Trabetti
authors.forename: C
authors.initials: C
authors.lastname: Stranieri
authors.forename: O
authors.initials: O
authors.lastname: Olivieri
authors.forename: E
authors.initials: E
authors.lastname: Tinazzi
authors.forename: N
authors.initials: N
authors.lastname: Martinelli
authors.forename: G
authors.initials: G
authors.lastname: Faccini
authors.forename: P F
authors.initials: PF
authors.lastname: Pignatti
authors.forename: R
authors.initials: R
authors.lastname: Corrocher
mesh_terms: D000368:Aged; D003324:Coronary Artery Disease / Q000097:blood / Q000201:enzymology* / Q000235:genetics; D005260:Female; D005492:Folic Acid / Q000097:blood*; D005787:Gene Frequency; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007558:Italy; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008875:Middle Aged; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics* / Q000378:metabolism; D011110:Polymorphism, Genetic; D012307:Risk Factors
chemical_list: D006710:Homocysteine; D005492:Folic Acid; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2)